Double-blind, randomized, placebo-controlled phase I study, to study the tolerability and immunogenicity of 4 RUTI antituberculous vaccine different doses (5, 25, 100 y 200microg of FCMtb) in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 29 May 2009
At a glance
- Drugs Tuberculosis vaccine (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 29 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2007 New trial record.